Company profile: Encodia
1.1 - Company Overview
Company description
- Provider of next-generation protein analysis tools, including ProteoCode for scalable protein sequencing that supports population-level studies and multiomic integration; NGS-based protein analysis using amino acid barcoded libraries; DNA library creation from peptide sequences; and affinity reagent binders with DNA barcode tags for sequencing amino acids in peptides.
Products and services
- DNA library creation from peptide sequences: Reverse translates peptide sequence information into a DNA library enabling scaled proteomics research, scalable and built from peptide-derived sequence data
- NGS-based protein analysis: Uses amino acid barcoded libraries for protein analysis with scale and throughput comparable to genomics technologies, genomics-scale for high-throughput proteomic interrogation
- ProteoCode: A technology for protein sequencing that scales for population-level studies and integrates with multiomic approaches for personalized medicine, population-scale for multiomic personalization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Encodia
Nanalysis
HQ: Canada
Website
- Description: Provider of portable benchtop nuclear magnetic resonance (NMR) spectrometers and supporting software for biotech, pharmaceutical, research, and education applications. Offerings include 100 MHz and 60 MHz NMR spectrometers, NMReady-CONNECT for remote control/monitoring, pulse sequence design, time-based kinetics experiments, and IQ/OQ modules for performance validation and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanalysis company profile →
Element Biosciences
HQ: United States
Website
- Description: Provider of innovative genetic analysis tools, including the AVITI System benchtop sequencer with dual flow cell capacity; AVITI24 integrating sequencing and Teton CytoProfiling to analyze DNA, RNA, proteins, and cell morphology from a single sample; Teton Assays targeting oncology, immunology, neuroscience; Cloudbreak Freestyle Kits to streamline AVITI workflows; and Avidity Sequencing for highly accurate, efficient data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Element Biosciences company profile →
Xpand Biotech
HQ: The Netherlands
Website
- Description: Provider of bone repair and regeneration products based on proprietary surface science technology, with in-house R&D, manufacturing, and clean room facilities; based in Bilthoven, The Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xpand Biotech company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
S-Biomedic
HQ: United States
Website
- Description: Provider of skin microbiome therapeutic solutions using targeted modulation-based technology, offering Living Skin Probiotics (Cutibacterium) to aid recovery of a healthy microbiome, Sencyr Microbiome Care for acne-prone skin, CutiNaturalis Probiotic to restore microbiome balance, proprietary Modulation Technology to restore beneficial bacteria, and Living Skin Postbiotics from skin commensals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full S-Biomedic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Encodia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Encodia
2.2 - Growth funds investing in similar companies to Encodia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Encodia
4.2 - Public trading comparable groups for Encodia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →